Sequoia Financial Advisors LLC Makes New $342,000 Investment in Chemed Corporation $CHE

Sequoia Financial Advisors LLC acquired a new stake in shares of Chemed Corporation (NYSE:CHE) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 703 shares of the company’s stock, valued at approximately $342,000.

Several other large investors have also recently made changes to their positions in the company. Kayne Anderson Rudnick Investment Management LLC lifted its position in shares of Chemed by 2.6% in the first quarter. Kayne Anderson Rudnick Investment Management LLC now owns 597,175 shares of the company’s stock worth $367,454,000 after buying an additional 15,041 shares in the last quarter. Neuberger Berman Group LLC increased its stake in Chemed by 3.9% in the 1st quarter. Neuberger Berman Group LLC now owns 521,212 shares of the company’s stock worth $320,712,000 after acquiring an additional 19,650 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Chemed by 9.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 218,675 shares of the company’s stock worth $134,547,000 after acquiring an additional 19,421 shares in the last quarter. Northern Trust Corp boosted its position in shares of Chemed by 3.4% during the 1st quarter. Northern Trust Corp now owns 215,523 shares of the company’s stock valued at $132,616,000 after acquiring an additional 6,988 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of Chemed by 9.4% in the first quarter. Charles Schwab Investment Management Inc. now owns 148,920 shares of the company’s stock valued at $91,633,000 after purchasing an additional 12,738 shares in the last quarter. 95.85% of the stock is owned by institutional investors.

Insider Transactions at Chemed

In other Chemed news, Director Patrick P. Grace sold 150 shares of the company’s stock in a transaction on Tuesday, September 9th. The stock was sold at an average price of $463.39, for a total value of $69,508.50. Following the completion of the sale, the director directly owned 3,397 shares in the company, valued at approximately $1,574,135.83. This represents a 4.23% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director George J. Walsh III purchased 200 shares of the company’s stock in a transaction dated Monday, August 4th. The shares were purchased at an average cost of $417.10 per share, for a total transaction of $83,420.00. Following the transaction, the director directly owned 3,523 shares in the company, valued at approximately $1,469,443.30. This represents a 6.02% increase in their position. The disclosure for this purchase can be found here. Insiders have sold a total of 13,162 shares of company stock worth $5,677,511 over the last three months. Company insiders own 3.29% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the stock. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, October 8th. Oppenheimer reduced their target price on shares of Chemed from $650.00 to $580.00 and set an “outperform” rating on the stock in a report on Thursday, July 31st. Jefferies Financial Group raised shares of Chemed from a “hold” rating to a “buy” rating and increased their price target for the company from $490.00 to $550.00 in a report on Tuesday, September 2nd. Royal Bank Of Canada dropped their price target on Chemed from $640.00 to $589.00 and set an “outperform” rating for the company in a research report on Thursday, July 31st. Finally, Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a research report on Saturday, July 5th. Four investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, Chemed currently has a consensus rating of “Moderate Buy” and a consensus price target of $578.50.

Chemed Stock Down 0.7%

CHE stock opened at $441.75 on Wednesday. Chemed Corporation has a twelve month low of $408.42 and a twelve month high of $623.60. The firm has a market cap of $6.44 billion, a price-to-earnings ratio of 22.71, a PEG ratio of 2.59 and a beta of 0.43. The business’s fifty day simple moving average is $449.11 and its two-hundred day simple moving average is $501.36.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $4.27 EPS for the quarter, missing analysts’ consensus estimates of $6.02 by ($1.75). The company had revenue of $618.80 million during the quarter, compared to the consensus estimate of $650.60 million. Chemed had a return on equity of 25.83% and a net margin of 11.56%.The company’s revenue for the quarter was up 3.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $5.47 earnings per share. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. Research analysts expect that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 11th were paid a dividend of $0.60 per share. This is a boost from Chemed’s previous quarterly dividend of $0.50. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend was Monday, August 11th. Chemed’s payout ratio is presently 12.34%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.